indocyanine green · Novadaq Tech · NDA 211580
Spy Agent Green Kit
Earliest generic entry, as listed
14 Jul 2039
Blocked by patent: US 11712320.
Listed patents · 5 unexpired
6 Orange Book listing rows for 5 patents. FDA lists a patent once for each use code, and lists its pediatric extension as a separate row.
| Patent | Claims | Expires |
|---|---|---|
| US 11712320 | drug product · sets the listed date | 14 Jul 2039 |
| US 10631746 | drug product, use U-2815 | 4 Aug 2035 |
| US 8406860 | use U-2463 | 9 Apr 2029 |
| US 8647605 | use U-2464, U-2468 | 11 Feb 2029 |
| US 8647605 listing row | use U-2464 | 11 Feb 2029 |
| US 8647605 listing row | use U-2468 | 11 Feb 2029 |
| US 8185176 | use U-2462 | 4 Jun 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 211580 · 001 · RLD | powder, intravenous, interstitial | 25MG/VIAL | 14 Jul 2039 |
Expired or delisted (1)
- I-911 · 5 Jun 2026